-
Product Insights
NewPostherpetic Neuralgia – Drugs In Development, 2024
Empower your strategies with our Postherpetic Neuralgia – Drugs In Development, 2024 report and make more profitable business decisions. Postherpetic neuralgia (PHN) emerges as the predominant long-term consequence of varicella-zoster virus (VZV) reactivation, commonly known as herpes zoster or shingles. VZV, responsible for childhood varicella (chickenpox), historically affected the majority of American adults before widespread vaccination. While future generations may experience lower rates of herpes zoster and PHN, the latter remains clinically significant. PHN diagnosis heavily relies on history and physical...
-
Product Insights
NewTrigeminal Neuralgia (Tic Douloureux) – Drugs In Development, 2024
Empower your strategies with our Trigeminal Neuralgia (Tic Douloureux) – Drugs In Development, 2024 report and make more profitable business decisions. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from the face to the brain. Symptoms include spontaneous attacks of pain or attacks triggered by things such as touching the face, chewing, speaking, and brushing teeth; pain in areas supplied by the trigeminal nerve, including the cheek, jaw, teeth, gums, lips, or less often...
-
Product Insights
Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Overview The Trigeminal Neuralgia (Tic Douloureux) clinical trial report consists of 129 trials. The report provides an overview of the Trigeminal Neuralgia (Tic Douloureux) clinical trials scenario. The report provides top-line data relating to the clinical trials on Trigeminal Neuralgia (Tic Douloureux). It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
Postherpetic Neuralgia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Postherpetic Neuralgia Clinical Trials Market Report Overview There were a total of 531 postherpetic neuralgia clinical trials conducted as of February 2023. The postherpetic neuralgia clinical trial market research report provides a comprehensive overview of the market across regions and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. The report includes information about the sponsor types and the prominent sponsors associated with the trials as well. Postherpetic Neuralgia Clinical Trials...
-
Sector Analysis
Diabetic Neuropathic Pain Market Size, Drug Analysis, Epidemiology, Disease Management, Pipeline Assessment, Unmet Needs and Forecast 2031
Diabetic Neuropathic Pain Market Report Overview The DNP market size across the 7MM was valued at $1.7 billion in 2021 and will achieve a CAGR of more than 2% during 2021-2031. The large prevalent population of patients with DNP, the high cost of drugs, and the number of drugs marketed exclusively in the US compared to other countries in the 7MM will drive market growth during the forecast period. Diabetic Neuropathic Pain Market Outlook, 2021-2031 ($ Billion) Buy the Full...